H Chabriat1,2,3, A Joutel3,4, E Tournier-Lasserve2,3,5, M G Bousser1,3. 1. Department of Neurology and CERVCO, Reference Center for Rare Vascular Diseases of the Eye and Brain, Hôpital Lariboisiére, APHP, Paris, France. 2. INSERM U 1141, Paris, France. 3. University of Paris, Paris, France. 4. Institute of Psychiatry and Neurosciences of Paris, INSERM U1266, Paris, France. 5. Molecular Genetics Department and CERVCO Reference Center for Rare Vascular Diseases of the Eye and Brain, Hopital Lariboisiére, APHP, Paris, France.
Abstract
BACKGROUND AND PURPOSE: In 2019, the Brain Prize crowned the discovery of CADASIL in the 1990s and research efforts on this archetypal small vessel disease of the brain over 40 years. METHODS AND RESULTS: The hereditary origin of this arteriolopathy was discovered from a first clinical case and detailed observation of the patient's family. Thereafter, the role of causative mutations within the NOTCH3 gene were identified, allowing the development of a genetic test and then of an animal model of the disease. These crucial steps led to the discovery progressively that CADASIL is the most common genetic cerebral small vessel disease, to describing for the first time the natural history of a cerebral ischaemic small vessel disease from silent cerebral tissue lesions up to severe motor disability and dementia at the end stage, to demonstrating the central role of matrix proteins in its pathophysiology and to opening the door to the discovery of several other genes involved in monogenic cerebral small vessel diseases. DISCUSSION: Today, CADASIL is known to every neurologist, but the disease has not yet revealed all its secrets. A lot of effort is still needed to understand the intimate mechanisms of the disease and the most efficient targets or approaches for the development of efficient therapeutics. The history of CADASIL will be further enriched by multiple ongoing research projects worldwide, at clinical and preclinical level, and will continue to enlighten research in the field of cerebral small vessel disorders.
BACKGROUND AND PURPOSE: In 2019, the Brain Prize crowned the discovery of CADASIL in the 1990s and research efforts on this archetypal small vessel disease of the brain over 40 years. METHODS AND RESULTS: The hereditary origin of this arteriolopathy was discovered from a first clinical case and detailed observation of the patient's family. Thereafter, the role of causative mutations within the NOTCH3 gene were identified, allowing the development of a genetic test and then of an animal model of the disease. These crucial steps led to the discovery progressively that CADASIL is the most common genetic cerebral small vessel disease, to describing for the first time the natural history of a cerebral ischaemic small vessel disease from silent cerebral tissue lesions up to severe motor disability and dementia at the end stage, to demonstrating the central role of matrix proteins in its pathophysiology and to opening the door to the discovery of several other genes involved in monogenic cerebral small vessel diseases. DISCUSSION: Today, CADASIL is known to every neurologist, but the disease has not yet revealed all its secrets. A lot of effort is still needed to understand the intimate mechanisms of the disease and the most efficient targets or approaches for the development of efficient therapeutics. The history of CADASIL will be further enriched by multiple ongoing research projects worldwide, at clinical and preclinical level, and will continue to enlighten research in the field of cerebral small vessel disorders.
Authors: Menno D Stellingwerff; Corinne Nulton; Guy Helman; Stefan D Roosendaal; William S Benko; Amy Pizzino; Marianna Bugiani; Adeline Vanderver; Cas Simons; Marjo S van der Knaap Journal: Neuropediatrics Date: 2022-02-23 Impact factor: 1.696
Authors: Selen C Muratoglu; Marc F Charette; Stacey J Sukoff Rizzo; M Luisa Iruela-Arispe; Zorina S Galis; Adam S Greenstein; Alan Daugherty; Anne Joutel; Beth A Kozel; Donna M Wilcock; Emily C Collins; Farzaneh A Sorond; Gareth R Howell; Hyacinth I Hyacinth; Kent K C Lloyd; Kurt R Stenmark; Manfred Boehm; Mark L Kahn; Roderick Corriveau; Sara Wells; Timothy J Bussey Journal: Arterioscler Thromb Vasc Biol Date: 2022-05-05 Impact factor: 10.514
Authors: Heidi I L Jacobs; Dorothee Schoemaker; Hei Torrico-Teave; Yesica Zuluaga; Lina Velilla-Jimenez; Carolina Ospina-Villegas; Francisco Lopera; Joseph F Arboleda-Velasquez; Yakeel T Quiroz Journal: Brain Connect Date: 2021-06-29
Authors: Fumiaki Oka; Jeong Hyun Lee; Izumi Yuzawa; Mei Li; Daniel von Bornstaedt; Katharina Eikermann-Haerter; Tao Qin; David Y Chung; Homa Sadeghian; Jessica L Seidel; Takahiko Imai; Doga Vuralli; Rosangela M Platt; Mark T Nelson; Anne Joutel; Sava Sakadzic; Cenk Ayata Journal: J Clin Invest Date: 2022-04-15 Impact factor: 19.456